ID’s Hollingshead Eye Center Invests in Optos Technology

Hollingshead Eye Center in Boise, Idaho, has announced it has invested in Optos 200Tx-AF ultra-widefield imaging technology, according to a news release.

Advertisement

 

The technology is intended to help detect the earliest signs of retinal diseases, and provide a digital record to help monitor the progression of the conditions.

 

“Optos 200Tx-AF® ultra-widefield imaging technology has been designed specifically for ophthalmologists and vitreoretinal specialists,” said Mark Hollingshead, MD, in the release. “The typical manual technique for examining the retina reveals only 10-12 percent of it at one time. The 200Tx-AF provides a panoramic map of more than 80 percent of the retina and gives us a new avenue of information that we haven’t had until now.”

 

Dr. Hollingshead opened Hollingshead Eye Center in 1994.

 

Related Articles on Ophthalmology:

Study: Patients on Statins at Lower Risk for Glaucoma

Ophthalmologist on the Move: Dr. George Baerveldt Joins CA’s NVISION Laser Eye Centers

Bausch + Lomb Receives FDA Approval of LOTEMAX Gel

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.